Cleveland Clinic has agreed to stop offering puberty blockers, cross-sex hormones, and other sex-rejection procedures to minors, and to set aside money for patients who later reverse those treatments. The deal, announced Friday, June 5, 2026, comes out of a national Justice Department probe into pediatric gender-transition care. The clinic has denied wrongdoing but accepted the settlement terms to resolve billing claims tied to those services.
What the Justice Department said
According to the Department of Justice, the Cleveland Clinic Foundation, working with Ohio Attorney General Dave Yost, agreed to a long-term pledge not to perform or offer sex-rejecting procedures for minors and to pay roughly $308,000 to resolve allegations of improper billing. The DOJ said the clinic will also dedicate $2 million to provide restorative care for detransitioners regardless of their insurance coverage. The department listed its Civil Division Enforcement and Affirmative Litigation Branch and the Commercial Litigation Branch, Fraud Section, as leading the investigation.
Officials' statements
“The Department of Justice is steadfastly committed to protecting America’s children,” Associate Attorney General Stanley Woodward said in the DOJ’s announcement. Assistant Attorney General Brett Shumate described the Cleveland Clinic’s financial pledge as an example of being “part of the solution” and said the Civil Division would keep pursuing providers it believes put minors at risk, according to the department.
How this echoes the Texas deal
The Cleveland Clinic outcome follows a similar settlement with Texas Children’s Hospital in mid-May that required a $10 million payment and the creation of a so-called “detransition” clinic, part of a broader effort by federal and state officials to scrutinize pediatric gender care, as reported by The Texas Tribune. That earlier deal has already fueled nationwide debate about clinical guidelines, state laws, and the legal exposure facing providers.
Clinic response and local impact
The Cleveland Clinic has rejected the allegations and says it cooperated with investigators throughout the inquiry, according to reporting by Townhall and the DOJ release. For patients and families in Northeast Ohio, the immediate on-the-ground change is that minors will no longer be offered puberty-blocking drugs or cross-sex hormones at Cleveland Clinic facilities under the agreement.
Legal implications
Officials stressed that the settlements resolve allegations and are not formal findings of liability. Billing disputes of this kind often fall under the federal False Claims Act, which allows the government or private whistleblowers to seek damages and penalties. For a short primer on that law, see the Legal Information Institute overview of the False Claims Act.
DOJ officials said the department will keep reviewing other providers and that state regulators may follow up with their own enforcement efforts. Cleveland Clinic patients, local lawmakers, and health advocates will now be watching how the promised restorative care is delivered, and whether this agreement becomes a template for broader policy changes.
